Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.
about
michGranulopoiesis-stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adultsGranulopoiesis-stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adultsChemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphomaChemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer riskChemotherapy only in early-stage Hodgkin lymphoma: more relapses but "same" (or possibly worse) survival--reconsidering the misguided trend to omit radiotherapyRole of chemotherapy in Hodgkin's lymphoma.Hodgkin's lymphoma therapy: past, present, and future.Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.Second primary breast cancer after Hodgkin's disease.Management of lymphoma in pregnancy.XVII. Radiotherapy in early stage Hodgkin lymphoma.Risk-adapted strategies for the treatment of Hodgkin lymphoma.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland.Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables.Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases.Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma.Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma.ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.Stage I-III Hodgkin's Disease: Outcome and Pattern of Failure Following Treatment with Radiation Therapy and Chemotherapy in a Modern Era
P2860
Q24186266-747EE01E-8C72-41C5-A3BC-47E7083E3A4EQ24200850-9EE75895-065C-4F1F-976C-8F2DCA555999Q24236589-EDC0DBDE-5840-4F5F-9195-1A77ADAADA87Q24245375-5B048469-74A2-47A0-A744-5725A2164728Q27015790-B122DCC8-D036-451E-803B-4125CE04A734Q33761103-293F6AEA-0B58-47D8-B9E4-E6B73272C00AQ34296914-24588722-DF50-4930-95D0-6010579CBF1AQ34617599-04D9E629-17FC-4D01-89FC-57772A2570A0Q35634560-8F41A5CB-EB4F-49A4-BF8C-1B2D466C2642Q37186296-8A487B7C-2B02-456F-8FCE-C3D0D303C849Q38115238-0D049CE7-10B7-44E8-BA2A-AF3974FF261FQ38591137-E5021722-C31A-4CA4-85C1-5DF72C03B33EQ38688797-181ED1CA-AACF-4F94-8E71-93E4A5C86917Q38912382-37453766-FEAE-4989-B12D-4F875E731D5AQ40044179-B8BB79F9-5C41-4C19-8129-A6B7BCF8C579Q40080086-80923FBD-C123-4E2D-B8E9-BB645B51923FQ40712492-7DA1D2B2-3734-410F-A4E9-E48F6C87495BQ41909027-4011FA50-0F02-4A4E-8D14-74DF37EDF3E8Q43526086-969DAB93-A720-4C8D-B779-95839A096E14Q46531267-235A6051-668B-42D9-9724-C2337DA13A96Q46738172-EFF399D7-26BD-4E26-A098-254911728A71Q47884628-743E9470-D3D7-4E86-B707-747A8D5F384CQ49932419-38AD2C79-1FB9-4548-8554-0B5E33863E29Q51296655-8478B004-E991-4B0B-9934-26A1BF9F3837Q51298132-F05C5EF5-1DB9-4503-849C-6B92B12D919DQ53899679-0B97BC68-3D53-4109-ABCC-90D7CF411AE9Q57770593-AF8C7B73-B60C-463A-BB00-ED3474F392A7
P2860
Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Influence of more extensive ra ...... s Disease Collaborative Group.
@ast
Influence of more extensive ra ...... s Disease Collaborative Group.
@en
Influence of more extensive ra ...... s Disease Collaborative Group.
@nl
type
label
Influence of more extensive ra ...... s Disease Collaborative Group.
@ast
Influence of more extensive ra ...... s Disease Collaborative Group.
@en
Influence of more extensive ra ...... s Disease Collaborative Group.
@nl
prefLabel
Influence of more extensive ra ...... s Disease Collaborative Group.
@ast
Influence of more extensive ra ...... s Disease Collaborative Group.
@en
Influence of more extensive ra ...... s Disease Collaborative Group.
@nl
P921
P1476
Influence of more extensive ra ...... 's Disease Collaborative Group
@en
P2093
P304
P356
10.1200/JCO.1998.16.3.830
P407
P577
1998-03-01T00:00:00Z